181 related articles for article (PubMed ID: 23852186)
1. Prescription of psychiatric medications and polypharmacy in the LAMS cohort.
Kowatch RA; Youngstrom EA; Horwitz S; Demeter C; Fristad MA; Birmaher B; Axelson D; Ryan N; Frazier TW; Arnold LE; Young AS; Gill M; Findling RL
Psychiatr Serv; 2013 Oct; 64(10):1026-34. PubMed ID: 23852186
[TBL] [Abstract][Full Text] [Related]
2. National trends in psychotropic medication polypharmacy in office-based psychiatry.
Mojtabai R; Olfson M
Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of children receiving antipsychotic medication.
Findling RL; Horwitz SM; Birmaher B; Kowatch RA; Fristad MA; Youngstrom EA; Frazier TW; Axelson D; Ryan N; Demeter CA; Depew J; Fields B; Gill MK; Deyling EA; Rowles BM; Arnold LE
J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):311-9. PubMed ID: 21851189
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Chronic Multiclass Psychotropic Polypharmacy and Psychotherapy in Foster Care Youth in a State Medicaid Population.
Keast SL; Tidmore LM; Shropshire D; Nesser N; Lambert TL
J Manag Care Spec Pharm; 2019 Dec; 25(12):1340-1348. PubMed ID: 31778625
[TBL] [Abstract][Full Text] [Related]
5. Psychotropic polypharmacy for the treatment of bipolar disorder in Taiwan.
Hung GC; Yang SY; Chen Y; Lin SK
Psychiatr Serv; 2014 Jan; 65(1):125-8. PubMed ID: 24382766
[TBL] [Abstract][Full Text] [Related]
6. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.
Comer JS; Olfson M; Mojtabai R
J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1001-10. PubMed ID: 20855045
[TBL] [Abstract][Full Text] [Related]
7. Psychotropic medication use in children and adolescents in an inpatient setting.
Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
[TBL] [Abstract][Full Text] [Related]
8. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.
Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T
BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250
[TBL] [Abstract][Full Text] [Related]
9. Psychotropic medication use in people living with severe and persistent mental illness in the Australian community: a cross-sectional study.
Hu J; McMillan SS; Theodoros T; Collins JC; El-Den S; O'Reilly CL; Wheeler AJ
BMC Psychiatry; 2022 Nov; 22(1):705. PubMed ID: 36380352
[TBL] [Abstract][Full Text] [Related]
10. Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns.
Kreyenbuhl JA; Valenstein M; McCarthy JF; Ganoczy D; Blow FC
Psychiatr Serv; 2007 Apr; 58(4):489-95. PubMed ID: 17412850
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
Deb S; Unwin G; Deb T
J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
[TBL] [Abstract][Full Text] [Related]
12. Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders.
Rhee TG; Rosenheck RA
J Affect Disord; 2019 Jun; 252():450-457. PubMed ID: 31004825
[TBL] [Abstract][Full Text] [Related]
13. Medication burden in bipolar disorder: a chart review of patients at psychiatric hospital admission.
Weinstock LM; Gaudiano BA; Epstein-Lubow G; Tezanos K; Celis-Dehoyos CE; Miller IW
Psychiatry Res; 2014 Apr; 216(1):24-30. PubMed ID: 24534121
[TBL] [Abstract][Full Text] [Related]
14. Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008.
Rosenberg RE; Mandell DS; Farmer JE; Law JK; Marvin AR; Law PA
J Autism Dev Disord; 2010 Mar; 40(3):342-51. PubMed ID: 19806445
[TBL] [Abstract][Full Text] [Related]
15. Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients.
Fontanella CA; Bridge JA; Campo JV
Ann Pharmacother; 2009 Dec; 43(12):1939-47. PubMed ID: 19934394
[TBL] [Abstract][Full Text] [Related]
16. Medication Adherence in Pediatric Patients with Bipolar Disorder: A Systematic Review.
Sanchez M; Lytle S; Neudecker M; McVoy M
J Child Adolesc Psychopharmacol; 2021 Mar; 31(2):86-94. PubMed ID: 33465006
[No Abstract] [Full Text] [Related]
17. Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.
Kulkarni J; Filia S; Berk L; Filia K; Dodd S; de Castella A; Brnabic AJ; Lowry AJ; Kelin K; Montgomery W; Fitzgerald PB; Berk M
BMC Psychiatry; 2012 Dec; 12():228. PubMed ID: 23244301
[TBL] [Abstract][Full Text] [Related]
18. Mental health treatment patterns in perinatally HIV-infected youth and controls.
Chernoff M; Nachman S; Williams P; Brouwers P; Heston J; Hodge J; Di Poalo V; Deygoo NS; Gadow KD;
Pediatrics; 2009 Aug; 124(2):627-36. PubMed ID: 19596734
[TBL] [Abstract][Full Text] [Related]
19. Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients' and practitioners' parameters in the MUSUBI study.
Adachi N; Azekawa T; Edagawa K; Goto E; Hongo S; Kato M; Katsumoto E; Kikuchi T; Kubota Y; Miki K; Nakagawa A; Tsuboi T; Ueda H; Watanabe K; Watanabe Y; Yasui-Furukori N; Yoshimura R
Hum Psychopharmacol; 2021 Mar; 36(2):e2764. PubMed ID: 33089907
[TBL] [Abstract][Full Text] [Related]
20. The Use of Antidepressants, Antipsychotics, and Stimulants in Youth Residential Care.
Oerbeck B; Overgaard KR; Hjellvik V; Lien L; Bramness JG
J Child Adolesc Psychopharmacol; 2021 Jun; 31(5):350-357. PubMed ID: 33635152
[No Abstract] [Full Text] [Related]
[Next] [New Search]
